null - FindTrial

N/A - FUTURE-MD-back pain 2011

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-001888-51-CZ

Enrollment

100

Registered

2011-08-22

Start date

2011-09-12

Completion date

Unknown

Last updated

2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low back pain

Interventions

Product Name: MD-Lumbar Pharmaceutical Form: Solution for injection Other descriptive name: COLLAGEN Concentration unit: % percent Concentration type: equal Concentration number: 0.015- Product Name:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 80 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s): ;Timepoint(s) of evaluation of this end point: the end of 5 weeks treatment period	—

Secondary

Measure	Time frame
Timepoint(s) of evaluation of this end point: the end of 5 weeks treatment period	—

Countries

Czech Republic

Contacts

Public ContactInpharm

Inpharm

zdenek.prochazka@edukafarm.cz0042224252435

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026